Statement of Financial Position [Abstract] Realized foreign currency translation loss from dissolution of subsidiaries Realized Foreign Currency Translation Loss From Dissolution Of Subsidiaries Represents the amount of realized foreign currency translation loss from dissolution of subsidiaries. Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive loss: Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] Basic loss per share (in Dollars per share) Earnings Per Share, Basic Diluted loss per share (in Dollars per share) Earnings Per Share, Diluted Change in fair value of warrant liabilities Change in fair value Change in fair value of warrant liabilities Fair Value Adjustment of Warrants Foreign currency (loss) gain Foreign currency gain/(loss) Gain (Loss), Foreign Currency Transaction, before Tax General and administrative General and Administrative Expense Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Income Statement [Abstract] Provision for income taxes Income Tax Expense (Benefit) Interest and dividends, net Investment Income, Interest and Dividend Net loss Net loss Segment and consolidated net loss Balance Balance Total stockholders’ equity Equity, Attributable to Parent Issuance of common stock at-the-market for cash, net of offering costs (in Shares) Stock Issued During Period, Shares, New Issues Issuance of common stock for cashless exercise of pre-funded warrants (in Shares) Stock Issued During Period, Shares, Other Issuance of common stock for exercise of pre-funded warrants (in Shares) Issuance of common stock Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Issuance of common stock at-the-market for cash, net of offering costs Stock Issued During Period, Value, New Issues Issuance of common stock for cashless exercise of pre-funded warrants Stock Issued During Period, Value, Other Issuance of common stock for exercise of pre-funded warrants Shares exercised value Stock Issued During Period, Value, Stock Options Exercised Change in fair value of warrant liabilities FairValueAdjustmentOfWarrant Amount of expense (income) related to adjustment to fair value of warrant liability. Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Additional Paid-in Capital Additional Paid-in Capital [Member] Reclassification to equity of the Placement Agent Warrants Liability Reclassification to equity of the placement agent warrants liability Adjustments to Additional Paid in Capital, Other -stock options APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition -warrants Adjustments to Additional Paid in Capital, Warrant Issued Common Stock Common Stock [Member] Common Stock [Member] Equity Component [Domain] Foreign currency translation Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax Accumulated Deficit Retained Earnings [Member] Balance (in Shares) Balance (in Shares) Shares, Outstanding Change in fair value of derivative warrant liability Fair Value Of Derivative Warrant Liability Amount of change in fair value of derivative warrant liability. Adjustments to reconcile net loss to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Cash and cash equivalents Cash and Cash Equivalent Cash, cash equivalents, and restricted cash - End of period Cash, cash equivalents, and restricted cash - Beginning of period Total cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Amortization expense Amortization Proceeds from exercises of pre-funded warrants Proceeds From Exercises Of Prefunded Warrants The cash inflow associated with the amount received from holders exercising their pre-funded stock warrants. Equity Components [Axis] Statement [Line Items] Statement of Stockholders' Equity [Abstract] Statement [Table] Other income, net Nonoperating Income (Expense) Operating expenses: Operating Expenses [Abstract] Loss from operations Operating Income (Loss) Foreign currency translation Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Other income Other Nonoperating Income Other income (expense): Other Nonoperating Income (Expense) [Abstract] Research and development Grant income Research and Development Expense Weighted-average common shares outstanding, diluted (in Shares) Weighted Average Number of Shares Outstanding, Diluted Weighted-average common shares outstanding, basic (in Shares) Weighted Average Number of Shares Outstanding, Basic Issuance of common stock in May 2025 public offering, net of offering costs Stock Issued During Period Issuance of Common Stock in Public Offering, Net of Offering Costs of Shares The amount of issuance of common stock in public offering, net of offering costs of shares. Issuance of common stock in May 2025 public offering, net of offering costs (in shares) Stock Issued During Period Issuance of Common Stock in Public Offering, Net of Offering Costs of Share The amount of issuance of common stock in public offering, net of offering costs of shares. Loss on asset write-off Loss on Asset Write-Off The amount of loss on asset write off. Issuance of common stock from the exercise of warrants, net Stock Issued During Period Shares Issuance Of Common Stock From The Exercise Of Warrants Net Issuance of common stock from the exercise of warrants, net. CASH FLOWS FROM FINANCING ACTIVITIES: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation CASH FLOWS FROM OPERATING ACTIVITIES: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Supplemental disclosures of non-cash activity: Noncash Investing and Financing Items [Abstract] Proceeds from sale of common stock under ATM agreement, net Net proceeds Proceeds from Issuance of Common Stock Restricted cash Restricted Cash, Current Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Statement of Cash Flows [Abstract] Supplemental disclosure of cash flow information: Supplemental Cash Flow Information [Abstract] NATURE OF THE ORGANIZATION AND BUSINESS Nature of Operations [Text Block] Nature of the Organization and Business [Abstract] Summary of Significant Accounting Policies and New Accounting Standards [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND NEW ACCOUNTING STANDARDS Significant Accounting Policies [Text Block] Intangible Assets [Abstract] INTANGIBLE ASSETS Intangible Assets Disclosure [Text Block] Stockholders’ Equity [Abstract] STOCKHOLDERS’ EQUITY Equity [Text Block] Stock Options [Abstract] STOCK OPTIONS Share-Based Payment Arrangement [Text Block] WARRANTS Warrants Text Block The disclosure of the warrants. Warrants [Abstract] Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Related Party Transactions Disclosure [Text Block] Proceeds from sale of common stock from public offerings, net Net proceeds public offering Proceeds from Issuance Initial Public Offering Proceeds from exercises of warrants Proceeds from Warrant Exercises Payments on financed director and officer insurance Payments of Financing Costs, Total Net Loss Per Common Share [Abstract] NET LOSS PER COMMON SHARE Earnings Per Share [Text Block] Public warrant liabilities Warrant liabilities - Representative warrants Warrants and Rights Outstanding Summary of Significant Accounting Policies and New Accounting Standards (Details) [Table] Maximum [Member] Maximum [Member] Schedule of Measured at Fair Value on a Recurring Basis [Line Items] Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Summary of Significant Accounting Policies and New Accounting Standards - Schedule of Measured at Fair Value on a Recurring Basis [Table] Schedule Of Measured At Fair Value On ARecurring Basis [Abstract] Representative Warrant liabilities [Member] Representative Warrant Liabilities Member Schedule of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Working capital Working Capital The amount of working capital. Accumulated deficit Retained Earnings (Accumulated Deficit) Exercises Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Anti-dilutive shares Diluted net loss per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Defined contribution Defined Contribution Plan, Cost Summary of Significant Accounting Policies and New Accounting Standards [Line Items] Federal depository insurance coverage Cash, FDIC Insured Amount Cash and cash equivalents Cash Equivalents, at Carrying Value Schedule Of Reconciliation Of The Level3 Representative Warrant Liabilities [Abstract] Reclassification to equity Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Reclassification to Equity Amount of reclassification to equity. Derivative Warrant Liabilities [Member] Derivative Warrant Liabilities Member Schedule of Relevant Translation Rates Schedule of Foreign Exchange Contracts, Statement of Financial Position [Table Text Block] Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Net Loss Per Share Earnings Per Share, Policy [Policy Text Block] Foreign Currency Translations Foreign Currency Transactions and Translations Policy [Policy Text Block] Translation of Foreign Operations Translation Of Foreign Operations Policy Text Block Disclosure of accounting policy for translation of foreign operations. Schedule of Intangible Assets, Net Schedule of Intangible Assets and Goodwill [Table Text Block] Schedule of Future Expected Amortization Expense of Intangible Assets Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Operating bank accounts and money market funds Cash Equivalent, Money Market Fund, Carrying Value Principles of Consolidation Consolidation, Policy [Policy Text Block] Fair Value, Recurring [Member] Fair Value, Recurring [Member] Financial Instruments [Domain] Financial Instrument [Axis] Schedule of Reconciliation of the Level 3 Representative Warrant Liabilities Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Comprehensive Loss Comprehensive Income, Policy [Policy Text Block] Acquisitions, Intangible Assets and Goodwill Goodwill and Intangible Assets, Policy [Policy Text Block] Impairment of Long-Lived Assets, Intangibles and Goodwill Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Leases Lessee, Leases [Policy Text Block] Stock-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Segment Information Segment Reporting, Policy [Policy Text Block] Minimum [Member] Minimum [Member] Statistical Measurement [Axis] Statistical Measurement [Domain] Foreign currency translation Foreign Currency Transaction Gain, before Tax Entity Interactive Data Current Entity Interactive Data Current Entity Registrant Name Entity Registrant Name Entity Shell Company Entity Shell Company Total assets Assets ASSETS Assets [Abstract] Total current assets Assets, Current Current assets: Assets, Current [Abstract] Preferred stock, par value $0.0001 per share, 5,000,000 shares authorized; 0 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively Preferred Stock, Value, Issued Segments [Axis] City Area Code City Area Code Total liabilities and stockholders’ equity Liabilities and Equity Total liabilities Liabilities Other segment items Segment Reporting, Other Segment Item, Amount Intangibles, net Net Remaining future amortization expense Finite-Lived Intangible Assets, Net Security Exchange Name Security Exchange Name Trading Symbol Trading Symbol Common stock, par value $0.0001 per share, 500,000,000 shares authorized; 33,414,448 shares and 23,091,062 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively Common stock Common Stock, Value, Issued Entity Emerging Growth Company Entity Emerging Growth Company Entity Current Reporting Status Entity Current Reporting Status Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Entity Central Index Key Entity Central Index Key Entity Address, State or Province Entity Address, State or Province Entity Address, Address Line One Entity Address, Address Line One Intangible Assets and Goodwill - Schedule of Intangible Assets, Net (Details) [Table] Common stock shares outstanding Common stock, shares outstanding (in Shares) Common Stock, Shares, Outstanding Common stock outstanding shares percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum Stock price Share Price Price per share Shares Issued, Price Per Share Cancellation of shares Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited Cancellation of shares, value Shares Issued, Value, Share-Based Payment Arrangement, Forfeited LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Total current liabilities Liabilities, Current Current liabilities: Liabilities, Current [Abstract] Total non-current liabilities Operating lease non current Class of Stock [Axis] Prepaid expenses ROU assets Plan Name [Domain] Stock options to purchase an aggregate shares (in Shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares Option total fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Strike price (in Dollars per share) Weighted average exercise price per share, Outstanding Ending Balance Weighted average exercise price per share, Outstanding Beginning Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Stock option issued under the plan (in Shares) Number of Options, Outstanding Ending Balance (in Shares) Stock option outstanding Number of Options, Outstanding Beginning Balance (in Shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Class of Warrant or Right [Table] Forfeitures shares (in Shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Stock Options [Line Items] Schedule of Stock Option Activity [Line Items] volatility Volatility rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected term Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Unused shares Common Stock, Capital Shares Reserved for Future Issuance Shares issued and paid but unexercised Warrants outstanding Class of Warrant or Right, Outstanding Issued common stock warrants purchase Class of Warrant or Right, Number of Securities Called by Warrants or Rights Warrants purchase Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Warrants exercise price Warrant per share value Class of Warrant or Right, Exercise Price of Warrants or Rights Class of Warrant or Right [Domain] Class of Warrant or Right [Axis] Exercise Price 0.84 [Member] Exercise Price Zero Point Eight Four [Member] Closing rate at period end Foreign Currency Translation Closing Rate Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency. Schedule Of Relevant Translation Rates [Abstract] Summary of Significant Accounting Policies and New Accounting Standards - Schedule of Relevant Translation Rates (Details) [Table] Series C Warrants [Member] Series CWarrants Member Series D Warrants [Member] Series DWarrants Member 2021 Stock Incentive Plan [Member] Two Thousand Twenty One Incentive Plan Member 2023 Plan [Member] Two Thousand Twenty Three Stock Incentive Plan Member Fair value of placement agent warrants Warrant liabilities - Placement Agent warrants Warrant Liabilities Placement Agent Warrants Warrant liabilities – placement agent warrants. Stock-Based Compensation [Member] Stock Based Compensation Member Stock Options [Table] Stock-based compensation expenses Share-Based Payment Arrangement, Expense Plan Name [Axis] Unamortized stock-based compensation expense Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Strike price (in Shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Accelerated Vesting, Number Vesting Period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period 2030 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Four 2029 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Three 2028 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Two Schedule of Future Expected Amortization Expense of Intangible Assets [Abstract] December 2025 Placement Agent Warrants [Member] December Two Thousand Twenty Five Placement Agent Warrants Member December 2025 Pre-Funded Warrants [Member] December Two Thousand Twenty FIVEPre Funded Warrants Member May 2025 Pre-Funded Warrant [Member] May2025 Pre Funded Warrant Member Number of aggregate authorized shares Numberof Aggregate Authorized Shares Number of aggregate authorized shares. Ownership Limitation [Member] Ownership Limitation Member Placement Agent Warrants [Member] Placement Agent Warrants Member Pre-Funded Warrants [Member] Pre Funded Warrants Member Private Investment in Public Equity (PIPE) Warrants [Member] Private Investment In Public Equity PIPEWarrants Member PIPE Warrants. Securities Purchase Agreements [Member] Securities Purchase Agreements Member Weighted average exercise price per share, Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Weighted average remaining contractual term (years), Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Number of Options, Granted (in Shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Aggregate intrinsic value, Outstanding Ending Balance (in Dollars) Aggregate intrinsic value, Outstanding Beginning Balance (in Dollars) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Warrants [Member] Warrants1 Member Investment, Name [Domain] Sale of Stock [Axis] Aggregate intrinsic value, Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Aggregate intrinsic value, Granted SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedIntrinsicValue1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedIntrinsicValue1 Aggregate intrinsic value, Expired/Cancelled Sharebased Compensation Arrangement By Sharebased Payment Award Options Expired And Cancelled Intrinsic Value1 Expired/Cancelled- Weighted average remaining contractual term (years), Granted Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term2 Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term2 Non-clinical research Non-Clinical Research Represents the amount of non-clinical research. 2027 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year One Schedule of Intangible Assets, Net [Line Items] Gross Carrying Amount Finite-Lived Intangible Assets, Gross Finite-Lived Intangible Assets by Major Class [Axis] Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Schedule Of Intangible Assets Net Abstract Series D Common Warrants [Member] Preferred stock, shares authorized Preferred stock, shares authorized (in Shares) Preferred Stock, Shares Authorized Document Type Document Type Document Transition Report Document Transition Report Document Quarterly Report Document Period End Date Document Period End Date Weighted average exercise price per share, Granted Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Clinical development Clinical Development Amount of clinical development. CMC CMCSegment Expenses The amount of cmc. Public Warrants [Member] Public Warrant Member Representative Warrants [Member] Representative Warrant Member Warrants [Table] Warrants [Line Items] Schedule of Warrants Exercisable [Line Items] Schedule of Warrant Activity [Line Items] Exercise Price 125.00 [Member] Exercise Price One Twenty Five Point Zero Zero [Member] Exercise Price 120.00 [Member] Exercise Price One Twenty Point Zero Zero [Member] Exercise Price 37.60 [Member] Exercise Price Thirty seven Point Six Zero [Member] Exercise Price 3.85 [Member] Exercise Price Three Point Eight Five [Member] Exercise Price 20.00 [Member] Exercise Price Twenty Point Zero Zero [Member] Exercise Price 0.94 [Member] Exercise Price Zero Point Nine Four [Member] Exercise Price 0.72 [Member] Exercise Price Zero Point Seven Two [Member] Number of warrants exercisable Share-Based Compensation Arrangement by Share-Based Payment Award Exercisable Number The number of shares into which fully or partially vested stock options outstanding. Weighted average exercise price, warrants exercisable Share-Based Compensation Arrangement by Share-Based Payment Award ,Exercisable, Weighted Average Exercise Price Share-based compensation arrangement by share-based payment award, exercisable, weighted average exercise price. Weighted-average remaining contractual term (years), warrants exercisable Share-Based Compensation Arrangement by Share-Based Payment Award Exercisable Weighted-Average Remaining Contractual Term Share-based compensation arrangement by share-based payment award, exercisable, weighted-average remaining contractual term. Weighted average exercise price Share Based Compensation Arrangement by Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price Per share or unit weighted-average fair value of award under share-based payment arrangement. Excludes share and unit options. Weighted-average remaining contractual term (years) Share Based Compensation Arrangement by Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Represent the Weighted average remaining contractual term of outstanding warrant, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Number of warrants Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number Exercise Price Range [Axis] Net Loss Per Common Share [Table] Exercise Price Range [Domain] Warrant [Member] Warrants [Member] Warrant [Member] Net Loss Per Common Share [Line Items] Schedule of Net Loss Per Share [Line Items] Stockholders’ Equity [Line Items] Common stock, par value (in Dollars per share) Common stock, par value Common Stock, Par or Stated Value Per Share Common stock, shares authorized (in Shares) Common stock, shares authorized Common Stock, Shares Authorized Common stock, shares issued (in Shares) Common stock shares issued Common Stock, Shares, Issued Preferred stock, par value (in Dollars per share) Preferred Stock, Par or Stated Value Per Share Preferred stock, shares issued (in Shares) Preferred Stock, Shares Issued Preferred stock, shares outstanding (in Shares) Preferred Stock, Shares Outstanding Issuance of common stock from the exercise of warrants, net Stock Issued During Period Value Issuance Of Common Stock From The Exercise Of Warrants Net Issuance of common stock from the exercise of warrants net. Reclassification to equity of the Placement Agent Warrants Liability The amount of reclassification to equity of the placement agent warrants liability. Issuance of common stock from the exercise of warrants, net Represents the amount of issuance of common stock from the exercise of warrants, net. Commitments and Contingencies [Abstract] COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Segment Information [Abstract] SEGMENT INFORMATION Segment Reporting Disclosure [Text Block] Reconciliation of cash, cash equivalents and restricted cash: Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract] NET CHANGE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Depreciation Depreciation Effect of foreign currency translation on cash Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Realized foreign currency translation loss from dissolution of subsidiaries Realized foreign currency translation loss from dissolution of subsidiaries Gain (Loss) on Disposition of Stock in Subsidiary Cash paid for taxes Income Taxes Paid, Net Accounts payable and accrued liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Other current assets Increase (Decrease) in Other Current Assets Prepaid expenses Increase (Decrease) in Prepaid Expense Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activity Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Schedule of Warrants Exercisable Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Schedule of Reconciliation to the Consolidated Net Loss Schedule of Segment Reporting Information, by Segment [Table Text Block] Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Derivative Financial Instruments Derivatives, Policy [Policy Text Block] Income Taxes Income Tax, Policy [Policy Text Block] Concentration of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Warrant Liability Warrant Liability Policy Text Block The accounting policy disclosure for Warrant Liability. Schedule of Measured at Fair Value on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Research and Development Research and Development Expense, Policy [Policy Text Block] General and Administrative Selling, General and Administrative Expenses, Policy [Policy Text Block] Defined-Contribution Savings Plan Defined Contribution Savings Plan Policy Text Block Disclosure of accounting policy for defined-contribution savings plan. Grants Grants Policy Text Block Disclosure of accounting policy for grants. Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Schedule of Net Loss Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Beginning balance Ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Related and Nonrelated Parties [Domain] Related and Nonrelated Parties [Axis] Schedule Of Net Loss Per Share [Abstract] Summary of Significant Accounting Policies and New Accounting Standards - Schedule of Net Loss Per Share [Table] Fair Value Hierarchy and NAV [Domain] Measurement Frequency [Domain] Significant unobservable inputs (Level 3) [Member] Fair Value, Inputs, Level 3 [Member] Fair Value, Inputs, Level 3 [Member] Significant other observable inputs (Level 2) [Member] Fair Value, Inputs, Level 2 [Member] Quoted prices in active markets for identical liabilities (Level 1) [Member] Fair Value, Inputs, Level 1 [Member] Measurement Frequency [Axis] Public Warrant liabilities [Member] Public Warrant Liabilities Member Change in fair value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) Issuances Placement agent warrant issuance costs Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value Hierarchy and NAV [Axis] Other income (expense) Other Nonoperating Income (Expense) Estimated useful lives Property, Plant and Equipment, Useful Life Common Stock Warrants Common Stock Warrants Policy Text Block Common stock warrants. Property and Equipment and Depreciation Property, Plant and Equipment, Policy [Policy Text Block] Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Deferred tax assets Deferred Tax Assets, Other Comprehensive income (loss) Other Comprehensive Income (Loss), Tax Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Grant Agreement [Member] Unrecognized tax benefits Unrecognized Tax Benefits, Beginning Balance Accrued for interest and penalties Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Stockholders' Equity [Table] Loss on warrant liability Change In Fair Value Of Derivative Warrant Liability Change in fair value of derivative warrant liability. Percentage of commission Commission Aggregate Gross Proceeds Percentage of commission aggregate gross proceeds. 2026 (remaining) Intangible Asset, Finite-Lived, Estimated Amortization Expense, Remainder of Fiscal Year Own beneficially percentage Equity Method Investment, Ownership Percentage IPO [Member] IPO [Member] Operating segment Number of Operating Segments Warrants, to purchase shares of Common Stock, par value $0.0001 per share Warrants To Purchase Shares Of Common Stock Par Value00001 Per Share Member Class of Stock [Domain] Current Fiscal Year End Date Current Fiscal Year End Date Document Fiscal Period Focus Document Fiscal Period Focus Document Fiscal Year Focus Document Fiscal Year Focus Document Information [Line Items] Document Information [Table] Accounts payable and accrued liabilities Operating lease current Accumulated other comprehensive income Accumulated Other Comprehensive Income (Loss), Net of Tax Additional paid-in capital Additional Paid in Capital Stockholders’ equity: Equity, Attributable to Parent [Abstract] Entity Small Business Entity Small Business Entity Tax Identification Number Entity Tax Identification Number Entity Ex Transition Period Entity Ex Transition Period Entity File Number Entity File Number Entity Filer Category Entity Filer Category Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Exercise price (in Dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price Discount rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions Unamortized stock-based compensation expense Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Schedule Of Warrants Exercisable Abstract Stock options term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsRemainingAmortizationPeriod Remaining amortization period. Warrants term Warrants and Rights Outstanding, Term Total operating and segment expenses Operating Segment Expenses The amount of operating and segment expenses. Reportable segment Number of Reportable Segments Impairment Intangible Assets, Net (Excluding Goodwill) In-process research and development [Member] In Process Research and Development [Member] Finite-Lived Intangible Assets, Major Class Name [Domain] Other current assets Other Assets, Current Reconciliation of net loss Segment Reporting, Measurement Disclosures [Abstract] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Address, City or Town Entity Address, City or Town Entity Address, Address Line Two Entity Address, Address Line Two Thereafter Finite Lived Intangible Assets Amortization Expense After Year Four Amount of amortization expense for finite-lived intangible asset expected to be recognized after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Excludes goodwill and capitalized cost for software to be sold, leased, or marketed. Weighted average remaining contractual term (years), Expired/Cancelled Share based Compensation Arrangement By Sharebased Payment Award Options Expired/Cancelled In Weighted Average Remaining Contractual Term Share-based compensation arrangement by share-based payment award options expired/cancelled in weighted average remaining contractual term. Location, Statement of Income, Balances [Axis] Amendment Flag Amendment Flag Local Phone Number Local Phone Number Title of 12(b) Security Title of 12(b) Security Schedule of Reconciliation to the Consolidated Net Loss [Abstract] General and administrative Other General and Administrative Expense Reporting Segment [Member] Reportable Segment, Aggregation before Other Operating Segment [Member] Schedule of Segment Reporting Information, by Segment [Table] Segments [Domain] Non-current liabilities Liabilities, Noncurrent [Abstract] Schedule of Reconciliation to the Consolidated Net Loss [Line Items] Segment Reporting [Line Items] Depreciation and amortization Depreciation, Depletion and Amortization Share based compensation expense Share-Based Payment Arrangement, Expense, after Tax Common Stock, par value $0.0001 per share Common Stock Par Value00001 Per Share Member Pre-clinical research Preclinical Research The amount of pre-clinical research. CODM, description Segment Reporting, Expense Information Used by CODM, Description Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] Common stock, voting rights Common Stock, Voting Rights Exercise Price 8.13 [Member] Exercise Price Eight Point One Three [Member] Exercise Price 5.13 [Member] Exercise Price Five Point One Three [Member] Exercise Price 1.40 [Member] Exercise Price One Point Four Zero [Member] Exercise Price 1.75 [Member] Exercise Price One Point Seven Five [Member] Currency [Axis] Schedule of Relevant Translation Rates [Line Items] Intra-Entity Foreign Currency Balance [Line Items] AUD to $USD [Member] Australia, Dollars All Currencies [Domain] Stock Options [Member] Equity Option [Member] Antidilutive Securities, Name [Domain] Antidilutive Securities [Axis] Aggregate net proceeds Aggregate Net Proceeds Aggregate net proceeds. ATM Agreement [Member] ATMAgreement Member Beneficial ownership limitation effective days Beneficial Ownership Limitation Effective Days Beneficial ownership limitation effective days. Average rate for period ended Foreign Currency Average Rate For Period Ended Average rate for period ended. Share-Based Payment Arrangement, Option [Member] Reduction in services Reduction in services. Services amount Related Party Transaction, Amounts of Transaction Weighted average exercise price per share, Expired/Cancelled Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Schedule Of Stock Option Activity Abstract Stock Options - Schedule of Stock Option Activity [Table] Number of Options, Expired/Cancelled (in Shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Expirations Number of Options, Exercisable (in Shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Weighted average remaining contractual term, Outstanding Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term May 2025 Placement Agent Warrants [Member] May2025 Placement Agent Warrants Member December 2025 Public Offering [Member] December Two Thousand Twenty Five Public Offering Member Gross proceeds Gross Proceeds Gross proceeds. Issuance of common stock from the exercise of pre-funded warrants Issued During Period Shares Issuance Of Common Stock From The Exercise Of Prefunded Warrants Net Number of issuance of common stock from the exercise of pre-funded warrants, net. Patents and intellectual property [Member] Patents [Member] Location, Statement of Income, Balances [Domain] Research And Development Expense One [Member] General And Administrative Expense One [Member] Investment, Name [Axis] Aggregate additional shares sold Sale of Stock, Consideration Received Per Transaction Restricted Stock Units [Member] Restricted Stock Units (RSUs) [Member] (EUR) to $USD [Member] Euro Member Countries, Euro (GBP) to $USD [Member] United Kingdom, Pounds Number of shares available for issuance Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Number of shares authorized Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Risk free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Sell aggregate share Sale of Stock, Number of Shares Issued in Transaction Sale of Stock [Domain] Liabilities [Abstract] 2023 Plan [Member] Two Thousand Twenty Three [Member] Chief Executive Officer